The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐up
暂无分享,去创建一个
[1] A. Patchefsky,et al. Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone , 1992, Cancer.
[2] U. Chetty,et al. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. , 1993, Human pathology.
[3] W. Dupont,et al. Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy , 1995, Cancer.
[4] S. Martino,et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. , 1999, The New England journal of medicine.
[5] W. Dupont,et al. Intraductal carcinoma of the breast: Follow‐up after biopsy only , 1982, Cancer.
[6] P. Rosen,et al. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. , 1978 .
[7] W. Dupont,et al. Atypical hyperplastic lesions of the female breast: A long-term follow-up study , 1986 .
[8] J Costantino,et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17 , 1999, Cancer.
[9] D. Page,et al. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. , 1992, Human pathology.
[10] P. Rosen,et al. The clinical significance of pre‐invasive breast carcinoma , 1980, Cancer.
[11] M. Lagios,et al. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence , 1989, Cancer.
[12] L Duchateau,et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] W D Dupont,et al. Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.